Steward Financial Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$5K Buy
+47
New +$6.26K ﹤0.01% 597
2023
Q2
Sell
-65
Closed -$9K 596
2023
Q1
$9K Buy
65
+50
+333% +$7.15K ﹤0.01% 205
2022
Q4
$2K Buy
+15
New +$2.16K ﹤0.01% 315
2022
Q3
Sell
-30
Closed -$3K 413
2022
Q2
$3K Buy
+30
New +$4.09K ﹤0.01% 434

Other funds holding DGX

Steward Financial Group's DGX Position: Q3 2023 in Review

Steward Financial Group opened a new position in Quest Diagnostics (DGX) in Q3 2023: 47 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #597 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in DGX as recently as Q1 2023.

Steward Financial Group first reported a position in DGX in Q2 2022 and has held it in 4 quarters since. The position peaked at $9K in Q1 2023. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Steward Financial Group held 47 shares of Quest Diagnostics worth $5K as of Q3 2023.
  • Quest Diagnostics was a new Steward Financial Group position in Q3 2023.
  • Quest Diagnostics made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #597 holding.
  • Steward Financial Group first reported a position in Quest Diagnostics in Q2 2022 and has held it in 4 quarters since.
  • Steward Financial Group's Quest Diagnostics position peaked at $9K in Q1 2023.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.